FLT3 and acute myeloid leukemia: Our study provides a treatment option with high efficacy, low cost, and minimal side effects for patients with FLT3-ITD AML and maybe shows a survival advantage for FLT3-combination therapy in patients with FLT3-ITD R/R AML.